Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment
AbbVie stock fell 10% after emraclidine, its drug for schizophrenia, failed during the final stages of its trials.
Abbvie Inc. (ABBV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 2,467,500 | $487,281,900 | -6% | 0.09% | |
| 2. | 1,868,100 | $368,912,388 | +140% | 0.07% | |
| 3. | AQR Capital Management Cliff Asness | 1,711,734 | $333,249,014 | +22% | 0.46% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 1,657,783 | $327,378,987 | +17% | 0.57% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,329,169 | $262,484,292 | +51% | 0.31% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | Officer | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | Officer | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | Officer | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | Officer | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $186.52 | 66,500 | 446,599 | 2024-08-05 | Filing | ||
| $175.00 | 282,845 | 513,099 | 2024-07-17 | Filing | ||
| $176.30 | 21,082 | 55,903 | 2024-03-20 | Filing | ||
| $178.69 | 27,740 | 60,941 | 2024-03-18 | Filing | ||
| $179.03 | 5,099 | 88,681 | 2024-03-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 160,398,281 | $24,856,921,606 | 0.54% | |
| 2. | 143,182,709 | $22,189,024,406 | 0.56% | |
| 3. | 78,200,866 | $12,118,788,204 | 0.58% | |
| 4. | 51,818,311 | $8,030,283,833 | 0.85% | |
| 5. | 44,988,183 | $6,971,795,864 | 1.56% |
News See All
10 Best Pharma Stocks To Buy Right Now
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of new treatments, and design...
AbbVie Inc. (NYSE:ABBV) Q3 2024 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to the AbbVie Third Quarter 2024 Earnings Conference Call.
Jim Cramer's Latest Lightning Round: 12 Stocks to Watch
On Tuesday, Jim Cramer, host of Mad Money, shared his thoughts on the market's recent volatility and offered advice to investors regarding earnings reports.
10 Best Medical Stocks to Buy Now
The medical and healthcare industry is one of the largest globally, with a steady demand for products and services due to the biological nature of humans. Stocks like Pfizer Inc.
Goldman Sachs' List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks
As the fourth quarter of 2024 starts, the market is once again back to debating about the Federal Reserve's interest rate cuts.
PGIM Jennison Health Sciences Fund Sold AbbVie (ABBV) in Q2. Here’s Why
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
8 Best Inexpensive Stocks To Invest In Now
The recent market surge has raised concerns about potential market overvaluation.
Must-See: Jim Cramer’s 10 Best Stock Picks for Investors Right Now
In a recent episode of Mad Money, Jim Cramer discussed how the slowing economy might lead the Federal Reserve to ease its policies.
10 Best Big-Name Stocks to Buy Right Now According to Short Sellers
In early April 2024, Goldman Sachs Inc.’s data revealed that short selling on individual US-listed stocks was at the highest level in 6 months, and the most targeted sectors were technology, telecom...
Billionaire Hedge Funds
